<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Mid Day Module (Medicine 9)   2024 12 21</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Mid Day Module (Medicine 9)   2024 12 21</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                50 Questions | 200 Total Marks | 60 min Duration | ~72.0 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 50 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 60 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 50</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Mid Day Module (Medicine 9)   2024 12 21 - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 50</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 50 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "Which genetic abnormality defines double-hit lymphoma (DHL)?", "options": [{"label": "A", "text": "t(14;18) with MYC overexpression", "correct": false}, {"label": "B", "text": "MYC translocation with BCL2 or BCL6 rearrangement", "correct": true}, {"label": "C", "text": "BCL2 translocation with BCL6 rearrangement", "correct": false}, {"label": "D", "text": "Trisomy 12 with BCL6 rearrangement", "correct": false}], "correct_answer": "B. MYC translocation with BCL2 or BCL6 rearrangement", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) MYC translocation with BCL2 or BCL6 rearrangement</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation</li><li>â€¢ :</li><li>â€¢ Option A. t(14;18) with MYC overexpression: While t(14;18) is associated with BCL2 overexpression and is seen in follicular lymphoma, it alone does not define DHL. DHL requires the additional presence of a MYC translocation.</li><li>â€¢ Option</li><li>â€¢ A. t(14;18) with MYC overexpression:</li><li>â€¢ Option C. BCL2 translocation with BCL6 rearrangement: This combination of rearrangements is not characteristic of DHL. DHL specifically requires a MYC translocation.</li><li>â€¢ Option</li><li>â€¢ C. BCL2 translocation with BCL6 rearrangement:</li><li>â€¢ Option D. Trisomy 12 with BCL6 rearrangement: Trisomy 12 is associated with chronic lymphocytic leukemia (CLL), and while BCL6 rearrangement can occur in various lymphomas, this combination does not define DHL.</li><li>â€¢ Option</li><li>â€¢ D. Trisomy 12 with BCL6 rearrangement:</li><li>â€¢ Educational objective :</li><li>â€¢ Educational objective</li><li>â€¢ :</li><li>â€¢ The combined dysregulation of MYC and BCL2/BCL6 is the defining feature of DHL.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is NOT a standard treatment option for mantle cell lymphoma (MCL)?", "options": [{"label": "A", "text": "R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone)", "correct": false}, {"label": "B", "text": "Bendamustine-rituximab (BR)", "correct": false}, {"label": "C", "text": "HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine)", "correct": false}, {"label": "D", "text": "ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)", "correct": true}], "correct_answer": "D. ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)</strong></p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following chemotherapy regimens is NOT typically used as a first-line treatment for symptomatic follicular lymphoma (FL)?", "options": [{"label": "A", "text": "R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone)", "correct": false}, {"label": "B", "text": "R-CVP (Rituximab, Cyclophosphamide, Vincristine, Prednisone)", "correct": false}, {"label": "C", "text": "Bendamustine-rituximab (BR)", "correct": false}, {"label": "D", "text": "HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine)", "correct": true}], "correct_answer": "D. HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine)", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation</li><li>â€¢ :</li><li>â€¢ Option A. R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone): This is a widely used and effective first-line treatment for FL. It combines the monoclonal antibody rituximab with a standard chemotherapy regimen (cyclophosphamide, doxorubicin, vincristine, and prednisone).</li><li>â€¢ Option</li><li>â€¢ A. R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone):</li><li>â€¢ Option B. R-CVP (Rituximab, Cyclophosphamide, Vincristine, Prednisone): This is another commonly used first-line regimen for FL, particularly in older or less fit patients. It is similar to R-CHOP but uses vincristine instead of doxorubicin, which is associated with less cardiotoxicity.</li><li>â€¢ Option</li><li>â€¢ B. R-CVP (Rituximab, Cyclophosphamide, Vincristine, Prednisone):</li><li>â€¢ Option C. Bendamustine-rituximab (BR): This is a well-tolerated and effective regimen that has gained popularity as a first-line treatment for FL, especially in patients who may not tolerate the anthracycline component of R-CHOP.</li><li>â€¢ Option</li><li>â€¢ C. Bendamustine-rituximab (BR):</li><li>â€¢ Educational objective :</li><li>â€¢ Educational objective</li><li>â€¢ :</li><li>â€¢ FL is typically treated with less intensive chemotherapy regimens compared to aggressive lymphomas.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following laboratory findings is characteristic of hairy cell leukemia (HCL)?", "options": [{"label": "A", "text": "Positive tartrate-resistant acid phosphatase (TRAP) stain", "correct": true}, {"label": "B", "text": "Positive myeloperoxidase (MPO) stain", "correct": false}, {"label": "C", "text": "Increased serum uric acid levels", "correct": false}, {"label": "D", "text": "BCR-ABL1 fusion gene", "correct": false}], "correct_answer": "A. Positive tartrate-resistant acid phosphatase (TRAP) stain", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) Positive tartrate-resistant acid phosphatase (TRAP) stain</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation</li><li>â€¢ :</li><li>â€¢ Option B. Positive myeloperoxidase (MPO) stain: MPO is an enzyme found in myeloid cells (neutrophils, eosinophils, and monocytes) and is used to diagnose myeloid leukemias. It is not typically positive in HCL.</li><li>â€¢ Option</li><li>â€¢ B. Positive myeloperoxidase (MPO) stain:</li><li>â€¢ Option C. Increased serum uric acid levels: While elevated uric acid levels can be seen in various hematologic malignancies due to increased cell turnover, it is not a specific finding for HCL.</li><li>â€¢ Option</li><li>â€¢ C. Increased serum uric acid levels:</li><li>â€¢ Option D. BCR-ABL1 fusion gene: This genetic abnormality is the hallmark of chronic myeloid leukemia (CML) and is not associated with HCL.</li><li>â€¢ Option</li><li>â€¢ D. BCR-ABL1 fusion gene:</li><li>â€¢ Educational objective :</li><li>â€¢ Educational objective</li><li>â€¢ :</li><li>â€¢ A positive TRAP stain is a useful diagnostic clue for hairy cell leukemia.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is a potential adverse effect of venetoclax, a BCL2 inhibitor used in CLL/SLL treatment?", "options": [{"label": "A", "text": "Tumor lysis syndrome", "correct": true}, {"label": "B", "text": "Atrial fibrillation", "correct": false}, {"label": "C", "text": "Diarrhea", "correct": false}, {"label": "D", "text": "Peripheral neuropathy", "correct": false}], "correct_answer": "A. Tumor lysis syndrome", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) Tumor lysis syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation</li><li>â€¢ :</li><li>â€¢ Option B. Atrial fibrillation: While cardiac arrhythmias can be a side effect of some cancer therapies, atrial fibrillation is not a common side effect specifically associated with venetoclax.</li><li>â€¢ Option</li><li>â€¢ B. Atrial fibrillation:</li><li>â€¢ Option C. Diarrhea: Diarrhea is a common side effect of many chemotherapies but is not a characteristic side effect of venetoclax.</li><li>â€¢ Option</li><li>â€¢ C. Diarrhea:</li><li>â€¢ Option D. Peripheral neuropathy: Peripheral neuropathy (damage to peripheral nerves causing numbness, tingling, or pain) can be a side effect of certain chemotherapy agents, but it is not typically associated with venetoclax.</li><li>â€¢ Option</li><li>â€¢ D. Peripheral neuropathy:</li><li>â€¢ Educational objective :</li><li>â€¢ Educational objective</li><li>â€¢ :</li><li>â€¢ Monitoring for and preventing TLS is crucial when initiating venetoclax therapy in CLL/SLL.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following genetic abnormalities is associated with a poor prognosis in CLL/SLL?", "options": [{"label": "A", "text": "Del(13q)", "correct": false}, {"label": "B", "text": "Del(17p)", "correct": true}, {"label": "C", "text": "Mutated IgVH genes", "correct": false}, {"label": "D", "text": "Trisomy 12", "correct": false}], "correct_answer": "B. Del(17p)", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Del(17p)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation</li><li>â€¢ :</li><li>â€¢ Option A. Del(13q): This is the most common genetic abnormality in CLL/SLL and is associated with a favorable prognosis. It typically involves deletion of the microRNA genes miR-15a and miR-16-1, which regulate B-cell survival.</li><li>â€¢ Option</li><li>â€¢ A. Del(13q):</li><li>â€¢ Option C. Mutated IgVH genes: CLL/SLL cases with mutated IgVH genes generally have a more indolent course and better prognosis compared to those with unmutated IgVH genes.</li><li>â€¢ Option</li><li>â€¢ C. Mutated IgVH genes:</li><li>â€¢ Option D. Trisomy 12: This is an intermediate-risk genetic abnormality in CLL/SLL, with a prognosis between that of del(13q) and del(17p). It can be associated with atypical morphology and increased proliferative activity.</li><li>â€¢ Option</li><li>â€¢ D. Trisomy 12:</li><li>â€¢ Educational objective :</li><li>â€¢ Educational objective</li><li>â€¢ :</li><li>â€¢ del(17p) is a high-risk genetic abnormality in CLL/SLL.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 60-year-old man presents with generalized erythroderma (redness of the skin), intense pruritus, and lymphadenopathy. Peripheral blood smear reveals atypical lymphocytes with cerebriform nuclei. Which of the following is the most likely diagnosis?", "options": [{"label": "A", "text": "Atopic dermatitis", "correct": false}, {"label": "B", "text": "Psoriasis", "correct": false}, {"label": "C", "text": "Mycosis fungoides (MF)", "correct": false}, {"label": "D", "text": "SÃ©zary syndrome (SS)", "correct": true}], "correct_answer": "D. SÃ©zary syndrome (SS)", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) SÃ©zary syndrome (SS)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation</li><li>â€¢ :</li><li>â€¢ Option A. Atopic dermatitis: While atopic dermatitis can cause itchy skin, it usually presents with localized patches of dry, scaly skin and does not typically cause erythroderma or lymphadenopathy. It also doesn